Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Number of holders
-
195
-
Total 13F shares, excl. options
-
87,359,094
-
Shares change
-
-2,896,716
-
Total reported value, excl. options
-
$1,793,463,324
-
Value change
-
-$71,085,162
-
Put/Call ratio
-
29%
-
Number of buys
-
111
-
Number of sells
-
-76
-
Price
-
$20.53
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q2 2024
221 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q2 2024.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 195 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87,359,094 shares
.
Largest 10 shareholders include BlackRock Inc. (7,906,765 shares), WELLINGTON MANAGEMENT GROUP LLP (7,339,004 shares), Kynam Capital Management, LP (5,722,057 shares), VANGUARD GROUP INC (4,797,089 shares), Avoro Capital Advisors LLC (3,888,437 shares), STATE STREET CORP (3,622,335 shares), Eversept Partners, LP (3,613,631 shares), Avidity Partners Management LP (3,335,000 shares), Point72 Asset Management, L.P. (2,782,853 shares), and Sofinnova Investments, Inc. (2,153,669 shares).
This table shows the top 195 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.